Upgrade: phase 1 combination trial of the napi2b-directed antibody drug conjugate (adc) upifitamab rilsodotin (upri; xmt-1536) in patients with ovarian cancer
Gynecologic Oncology Reports（2022）
关键词
ovarian cancer,antibody drug conjugate,upifitamab rilsodotin,b-directed
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要